William Weldon is Chairman and Chief Executive Officer of Johnson & Johnson and is the sixth Chairman in Johnson & Johnson's over one-hundred year history.
Weldon joined J&J as a sales representative for the McNeil Pharameutical division in 1971 and eventually became the head of J&J's Ethicon Endo-Surgery business in 1992. He became the head of J&J's pharmaceutical operations in 1998 and then became J&J's CEO in 2002. As CEO, Weldon engineered some of the largest acquisitions in J&J's history including the purchase of ALZA and Pfizer's consumer-health product line.
William Weldon received a BA in Biology from Quinnipiac University.
It's really interesting because one of the challenges we have at J&J is that consumer business is very different...and if you take the two extremes - consumer and pharm - consumer comes out with about 600 new products a year, our consumer businesses, our pharm products if we come out with half a doz...(Full transcript available to logged in subscribers.).
Register & Subscribe
Login
